1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Joseph Oved: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition Emapalumab, Fludarabine and Dexamethasone, Allogeneic hematopoietic stem cell transplant (allo-HCT) - Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative | Phase 2 | Recruiting | Joseph Oved | 39 | 2023-03-15 | 2026-06-02 |
Dexamethasone (1) · Emapalumab (1) · Stem Cell Transplantation (1) · fludarabine (1)
United States (1)